tiprankstipranks
Trending News
More News >
BAB Inc (BABB)
OTHER OTC:BABB
US Market
Advertisement

BAB (BABB) AI Stock Analysis

Compare
92 Followers

Top Page

BABB

BAB

(OTC:BABB)

Select Model
Select Model
Select Model
Outperform 79 (OpenAI - 4o)
Rating:79Outperform
Price Target:
$1.00
▲(5.26% Upside)
BAB's strong financial performance and attractive valuation are the primary drivers of its score. The technical analysis supports a positive outlook, with the stock showing upward momentum. The absence of earnings call data and corporate events does not detract from the overall positive assessment.

BAB (BABB) vs. SPDR S&P 500 ETF (SPY)

BAB Business Overview & Revenue Model

Company DescriptionBAB, Inc. franchises and licenses bagel and muffin retail units under the Big Apple Bagels (BAB), My Favorite Muffin (MFM), and SweetDuet (SD) trade names in the United States. It's BAB franchised brand consists of daily baked bagels, flavored cream cheeses, premium coffees, gourmet bagel sandwiches, and other related products. The company's MFM brand comprise of various freshly baked muffins and coffees; and units operating as My Favorite Muffin Your All Day Bakery Café featuring specialty bagel sandwiches and related products. Its SD brand includes frozen yogurt products. As of November 30, 2021, the company had 68 franchise units and 4 licensed units in operation in 20 states. BAB, Inc. was incorporated in 2000 and is based in Deerfield, Illinois.
How the Company Makes MoneyBAB generates revenue through multiple streams, primarily by charging fees for its digital banking services, such as transaction fees for payment processing and monthly account maintenance fees for businesses. Additionally, the company earns interest income from loans issued to SMEs, as well as potential revenue from ancillary services like financial advisory and consulting. Strategic partnerships with other fintech platforms and banks also play a crucial role in expanding BAB's offerings and customer base, allowing for cross-selling opportunities that enhance overall profitability.

BAB Financial Statement Overview

Summary
BABB demonstrates strong financial health with robust profit margins, effective cost management, and strong equity positions. The income statement, balance sheet, and cash flow statements are all solid, although there are minor areas to monitor. Overall, the company shows strong potential for sustained growth and profitability.
Income Statement
85
Very Positive
The company shows a strong gross profit margin close to 100%, indicating efficient cost management. The net profit margin has improved significantly from negative in 2020 to positive in 2025 TTM, reflecting enhanced profitability. Revenue growth has been consistent, with a notable increase from 2020 to 2025. EBIT and EBITDA margins are robust, highlighting operational efficiency. The overall trajectory is positive, showing strong profitability and growth.
Balance Sheet
78
Positive
The balance sheet is solid, with a low debt-to-equity ratio indicating low financial leverage. The return on equity is healthy, suggesting effective use of equity to generate profits. The equity ratio is strong, reflecting a stable financial position with substantial equity backing assets. However, the slight decrease in total assets in recent years indicates a need for monitoring.
Cash Flow
80
Positive
Cash flow performance is solid with consistent free cash flow growth, indicating strong cash generation capabilities. The operating cash flow to net income ratio suggests efficient cash conversion from profits. The free cash flow to net income ratio is also positive, highlighting good cash availability to support operations and investments. However, fluctuations in operating cash flow between years suggest potential volatility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.29M3.55M3.51M3.29M3.07M2.37M
Gross Profit3.10M3.55M3.51M3.18M2.09M1.70M
EBITDA749.19K681.08K618.58K612.21K874.72K236.95K
Net Income558.87K525.20K467.32K431.99K651.12K-66.17K
Balance Sheet
Total Assets4.92M4.84M4.30M4.29M4.46M4.09M
Cash, Cash Equivalents and Short-Term Investments2.03M2.18M1.89M1.62M1.46M1.24M
Total Debt346.82K378.06K39.82K153.70K260.09K587.40K
Total Liabilities1.50M1.50M1.12M1.22M1.53M1.52M
Stockholders Equity3.42M3.34M3.18M3.08M2.93M2.57M
Cash Flow
Free Cash Flow666.11K636.70K533.19K135.04K715.77K199.64K
Operating Cash Flow674.68K637.75K534.37K135.04K718.30K212.92K
Investing Cash Flow-12.97K-9.96K-1.18K0.00-2.52K-13.28K
Financing Cash Flow-435.81K-363.18K-363.18K-290.54K-290.54K-62.38K

BAB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.95
Price Trends
50DMA
0.96
Negative
100DMA
0.90
Positive
200DMA
0.86
Positive
Market Momentum
MACD
<0.01
Positive
RSI
46.58
Neutral
STOCH
26.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BABB, the sentiment is Positive. The current price of 0.95 is below the 20-day moving average (MA) of 0.97, below the 50-day MA of 0.96, and above the 200-day MA of 0.86, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 46.58 is Neutral, neither overbought nor oversold. The STOCH value of 26.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BABB.

BAB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$7.24M12.9616.66%6.31%-7.46%2.95%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
61
Neutral
$9.65M0.621.32%-15.44%-94.04%
56
Neutral
$10.47M
48
Neutral
$2.43M-0.20-3.22%-49.19%-394.71%
46
Neutral
$9.13M-0.57-45.00%-77.72%-282.16%
29
Underperform
$10.94M5.198.12%-82.25%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BABB
BAB
0.95
0.22
30.14%
PETZ
Tdh Holdings
1.06
-0.22
-17.19%
FAMI
Farmmi
1.85
-2.78
-60.04%
SOWG
Sow Good
0.75
-9.25
-92.50%
BON
Bon Natural Life
1.92
-34.83
-94.78%
HCWC
Healthy Choice Wellness Corp. Class A
0.70
-1.68
-70.59%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2025